1.
Changes in pathogens and pneumococcal serotypes causing community-acquired pneumonia in The Netherlands
2.
3.
Routine vaccination for influenza and pneumococcal disease and its effect on COVID-19 in a population of Dutch older adults
A post-hoc analysis of serotype-specific vaccine efficacy of 13-valent pneumococcal conjugate vaccine against clinical community acquired pneumonia from a randomized clinical trial...
Impact of 7-valent versus 10-valent pneumococcal conjugate vaccines on primary care consultations across various age groups in the Netherlands, 5 years after the switch: A time-ser...
Nasopharyngeal carriage of Streptococcus pneumoniae and other bacteria in the 7th year after implementation of the pneumococcal conjugate vaccine in the Netherlands